Jurisdiction
Switzerland
Switzerland regulates health products through Swissmedic, the Swiss Agency for Therapeutic Products, which authorises medicines and supervises medical devices. As a non-EU country, Switzerland maintains its own therapeutic products law while closely tracking EU frameworks such as the MDR and IVDR, and changes to the mutual recognition arrangement have reshaped device market access. This page collects the Swiss regulatory updates HealthSignal tracks across medicines and devices, from official public sources only.
Regulation
Category
Impact
Date
Revision of the Guidance document Packaging texts for veterinary medicinal products
01.07.2026
SwissmedicOut-of-Stock – Opdualag 240mg/80mg, Konzentrat zur Herstellung einer Infusionslösung
09.07.2026
Swissmedic
Showing 27 of 27 tracked updates
See all in the feed →